leadf
logo-loader
RNS
viewFeedback PLC

Feedback PLC - Director/PDMR Shareholding

RNS Number : 4314V
Feedback PLC
07 August 2020
 

Feedback plc

 

Grant of Director Options

 

 

London, 07 August 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that it has granted options over 13,498,748 new Ordinary Shares ("CEO Options"), representing 1.27 per cent. of the Company's issued share capital, to Tom Oakley, CEO of Feedback.

 

The CEO Options are exercisable at a price of 1.2 pence at any time up to the tenth anniversary of the date of grant.  One-third of the CEO Options vest immediately, one-third will vest one year from date of grant and the balance will vest two years from the date of the grant. The grant of the CEO Options and the issue price were approved by shareholders at the General Meeting of the Company held on 29 August 2019.  Of the CEO Options, 12,356,667 were granted pursuant to the EMI Option Scheme and the balance of 1,142,081 options were granted pursuant to the Non Tax-Advantaged Option Scheme.

 

Tom Oakley now hold options over 22,820,829 Ordinary Shares, equivalent to 2.14 % of the Company's voting rights. In total 60,330,829 Options are now outstanding, representing approximately 5.65 % of the Company's current issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Tom Oakley

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Feedback plc

b)

 

LEI

 

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Options over Ordinary Shares of 0.25p each in Feedback plc

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550

b)

 

Nature of the transaction

 

Grant of options

c)

 

Price(s) and volume(s)

 

 

Price(s)

Exercise price of

1.2p per share

Volume(s)

 

13,498,748

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

N/A

 

e)

 

Dates of the transaction

 

6 August 2020




f)

Place of transaction

Outside of a trading venue

 

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]



Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656



Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936



Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880



Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

+44 (0)20 7457 2020

+44 7890 022 814

[email protected]

 

Notes to editors

 

About Bleepa

 

Bleepa provides instant and remote access to clinical grade medical images through a zero footprint application.  The majority of patient cases require medical imaging which can be seamlessly shared to the entire clinical team through Bleepa.  Cases can be discussed through its secure instant messaging and image annotation, allowing comments and treatment decisions to be communicated instantly between team members.  Bleepa can be accessed from any internet connected device including phones, tablets, laptops and desktops; clinicians can use their own devices and therefore no additional hardware is required.

 

About Feedback plc - www.fbk.com

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited.  Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS).  For more information on Bleepa, see www.bleepa.com.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUPURWRUPUGBQ

Quick facts: Feedback PLC

Price: 1.05

Market: LSE
Market Cap: £11.2 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Restructure sees Feedback Plc positioned for growth

Alastair Riddell, chairman of Feedback plc (LON:FDBK), tells Proactive's Andrew Scott they've merged two of their subsidiaries as part of plans to restructure and simplify the business. Feedback snapped up Cambridge Computed Imaging and TexRAD back in 2014 and both have been operating as...

on 19/4/18

5 min read